Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 192 of 203 entries
Sorted by: Best Match Show Resources per page
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.

NPJ vaccines

Wuertz KM, Barkei EK, Chen WH, Martinez EJ, Lakhal-Naouar I, Jagodzinski LL, Paquin-Proulx D, Gromowski GD, Swafford I, Ganesh A, Dong M, Zeng X, Thomas PV, Sankhala RS, Hajduczki A, Peterson CE, Kuklis C, Soman S, Wieczorek L, Zemil M, Anderson A, Darden J, Hernandez H, Grove H, Dussupt V, Hack H, de la Barrera R, Zarling S, Wood JF, Froude JW, Gagne M, Henry AR, Mokhtari EB, Mudvari P, Krebs SJ, Pekosz AS, Currier JR, Kar S, Porto M, Winn A, Radzyminski K, Lewis MG, Vasan S, Suthar M, Polonis VR, Matyas GR, Boritz EA, Douek DC, Seder RA, Daye SP, Rao M, Peel SA, Joyce MG, Bolton DL, Michael NL, Modjarrad K.
PMID: 34711815
NPJ Vaccines. 2021 Oct 28;6(1):129. doi: 10.1038/s41541-021-00392-7.

The emergence of SARS-CoV-2 variants of concern (VOC) requires adequate coverage of vaccine protection. We evaluated whether a SARS-CoV-2 spike ferritin nanoparticle vaccine (SpFN), adjuvanted with the Army Liposomal Formulation QS21 (ALFQ), conferred protection against the Alpha (B.1.1.7), and...

Cite
Wuertz KM, Barkei EK, Chen WH, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. NPJ Vaccines. 2021;6(1):129doi: 10.1038/s41541-021-00392-7.
Wuertz, K. M., Barkei, E. K., Chen, W. H., Martinez, E. J., Lakhal-Naouar, I., Jagodzinski, L. L., Paquin-Proulx, D., Gromowski, G. D., Swafford, I., Ganesh, A., Dong, M., Zeng, X., Thomas, P. V., Sankhala, R. S., Hajduczki, A., Peterson, C. E., Kuklis, C., Soman, S., Wieczorek, L., Zemil, M., Anderson, A., Darden, J., Hernandez, H., Grove, H., Dussupt, V., Hack, H., de la Barrera, R., Zarling, S., Wood, J. F., Froude, J. W., Gagne, M., Henry, A. R., Mokhtari, E. B., Mudvari, P., Krebs, S. J., Pekosz, A. S., Currier, J. R., Kar, S., Porto, M., Winn, A., Radzyminski, K., Lewis, M. G., Vasan, S., Suthar, M., Polonis, V. R., Matyas, G. R., Boritz, E. A., Douek, D. C., Seder, R. A., Daye, S. P., Rao, M., Peel, S. A., Joyce, M. G., Bolton, D. L., Michael, N. L., & Modjarrad, K. (2021). A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. NPJ vaccines, 6(1), 129. https://doi.org/10.1038/s41541-021-00392-7
Wuertz, Kathryn McGuckin, et al. "A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge." NPJ vaccines vol. 6,1 (2021): 129. doi: https://doi.org/10.1038/s41541-021-00392-7
Wuertz KM, Barkei EK, Chen WH, Martinez EJ, Lakhal-Naouar I, Jagodzinski LL, Paquin-Proulx D, Gromowski GD, Swafford I, Ganesh A, Dong M, Zeng X, Thomas PV, Sankhala RS, Hajduczki A, Peterson CE, Kuklis C, Soman S, Wieczorek L, Zemil M, Anderson A, Darden J, Hernandez H, Grove H, Dussupt V, Hack H, de la Barrera R, Zarling S, Wood JF, Froude JW, Gagne M, Henry AR, Mokhtari EB, Mudvari P, Krebs SJ, Pekosz AS, Currier JR, Kar S, Porto M, Winn A, Radzyminski K, Lewis MG, Vasan S, Suthar M, Polonis VR, Matyas GR, Boritz EA, Douek DC, Seder RA, Daye SP, Rao M, Peel SA, Joyce MG, Bolton DL, Michael NL, Modjarrad K. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. NPJ Vaccines. 2021 Oct 28;6(1):129. doi: 10.1038/s41541-021-00392-7. PMID: 34711815; PMCID: PMC8553838.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;166:154-161doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 166154-161. https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 154-161. doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection.

Open forum infectious diseases

El Kamari V, Rodriguez K, Moser C, Currier JS, Kelesidis T, Stein JH, Brown TT, Howell SK, Beisswenger PJ, McComsey GA.
PMID: 34631914
Open Forum Infect Dis. 2021 Aug 16;8(10):ofab423. doi: 10.1093/ofid/ofab423. eCollection 2021 Oct.

BACKGROUND: Despite advances in antiretroviral therapy (ART), people living with human immunodeficiency virus (HIV) continue to be at increased risk of cardiometabolic complications compared to HIV-uninfected individuals. Advanced glycation end products (AGEs) are implicated in the development and progression...

Cite
El Kamari V, Rodriguez K, Moser C, et al. Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2021;8(10):ofab423doi: 10.1093/ofid/ofab423.
El Kamari, V., Rodriguez, K., Moser, C., Currier, J. S., Kelesidis, T., Stein, J. H., Brown, T. T., Howell, S. K., Beisswenger, P. J., & McComsey, G. A. (2021). Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection. Open forum infectious diseases, 8(10), ofab423. https://doi.org/10.1093/ofid/ofab423
El Kamari, Vanessa, et al. "Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection." Open forum infectious diseases vol. 8,10 (2021): ofab423. doi: https://doi.org/10.1093/ofid/ofab423
El Kamari V, Rodriguez K, Moser C, Currier JS, Kelesidis T, Stein JH, Brown TT, Howell SK, Beisswenger PJ, McComsey GA. Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2021 Aug 16;8(10):ofab423. doi: 10.1093/ofid/ofab423. eCollection 2021 Oct. PMID: 34631914; PMCID: PMC8496763.
Copy Download .nbib Format: NLM
Incidence of Osteoporosis-Related Complications Following Posterior Lumbar Fusion.

Global spine journal

Bjerke BT, Zarrabian M, Aleem IS, Fogelson JL, Currier BL, Freedman BA, Bydon M, Nassr A.
PMID: 30202709
Global Spine J. 2018 Sep;8(6):563-569. doi: 10.1177/2192568217743727. Epub 2017 Dec 10.

STUDY DESIGN: Retrospective review.OBJECTIVES: This study investigates the prevalence of adverse postsurgical events, or osteoporosis-related complications (ORCs), following spinal fusion.METHODS: Patients undergoing primary posterior thoracolumbar or lumbar fusion by 1 of 2 surgeons practicing at a single institution were...

Cite
Bjerke BT, Zarrabian M, Aleem IS, et al. Incidence of Osteoporosis-Related Complications Following Posterior Lumbar Fusion. Global Spine J. 2017;8(6):563-569doi: 10.1177/2192568217743727.
Bjerke, B. T., Zarrabian, M., Aleem, I. S., Fogelson, J. L., Currier, B. L., Freedman, B. A., Bydon, M., & Nassr, A. (2018). Incidence of Osteoporosis-Related Complications Following Posterior Lumbar Fusion. Global spine journal, 8(6), 563-569. https://doi.org/10.1177/2192568217743727
Bjerke, Benjamin T, et al. "Incidence of Osteoporosis-Related Complications Following Posterior Lumbar Fusion." Global spine journal vol. 8,6 (2018): 563-569. doi: https://doi.org/10.1177/2192568217743727
Bjerke BT, Zarrabian M, Aleem IS, Fogelson JL, Currier BL, Freedman BA, Bydon M, Nassr A. Incidence of Osteoporosis-Related Complications Following Posterior Lumbar Fusion. Global Spine J. 2018 Sep;8(6):563-569. doi: 10.1177/2192568217743727. Epub 2017 Dec 10. PMID: 30202709; PMCID: PMC6125926.
Copy Download .nbib Format: NLM
pearls.

The Physician and sportsmedicine

Harvey J, McKeag DB, Kleiman SG, Bays RP, Smith AD, Morrey B, Currier BL, Gunckle W.
PMID: 29281402
Phys Sportsmed. 1992 Jul;20(7):49-50. doi: 10.1080/00913847.1992.11947448.

No abstract available.

Cite
Harvey J, McKeag DB, Kleiman SG, et al. pearls. Phys Sportsmed. 1992;20(7):49-50doi: 10.1080/00913847.1992.11947448.
Harvey, J., McKeag, D. B., Kleiman, S. G., Bays, R. P., Smith, A. D., Morrey, B., Currier, B. L., & Gunckle, W. (1992). pearls. The Physician and sportsmedicine, 20(7), 49-50. https://doi.org/10.1080/00913847.1992.11947448
Harvey, Jack, et al. "pearls." The Physician and sportsmedicine vol. 20,7 (1992): 49-50. doi: https://doi.org/10.1080/00913847.1992.11947448
Harvey J, McKeag DB, Kleiman SG, Bays RP, Smith AD, Morrey B, Currier BL, Gunckle W. pearls. Phys Sportsmed. 1992 Jul;20(7):49-50. doi: 10.1080/00913847.1992.11947448. PMID: 29281402.
Copy Download .nbib Format: NLM
Position-Specific Body Composition Values in Female Collegiate Rugby Union Athletes.

Journal of strength and conditioning research

Harty PS, Zabriskie HA, Stecker RA, Currier BS, Moon JM, Richmond SR, Jagim AR, Kerksick CM.
PMID: 31403573
J Strength Cond Res. 2019 Aug 08; doi: 10.1519/JSC.0000000000003314. Epub 2019 Aug 08.

Harty, PS, Zabriskie, HA, Stecker, RA, Currier, BS, Moon, JM, Richmond, SR, Jagim, AR, and Kerksick, CM. Position-specific body composition values in female collegiate rugby union athletes. J Strength Cond Res XX(X): 000-000, 2019-Rugby union is a full-contact, intermittent...

Cite
Harty PS, Zabriskie HA, Stecker RA, et al. Position-Specific Body Composition Values in Female Collegiate Rugby Union Athletes. J Strength Cond Res. 2019;doi: 10.1519/JSC.0000000000003314.
Harty, P. S., Zabriskie, H. A., Stecker, R. A., Currier, B. S., Moon, J. M., Richmond, S. R., Jagim, A. R., & Kerksick, C. M. (2019). Position-Specific Body Composition Values in Female Collegiate Rugby Union Athletes. Journal of strength and conditioning research, . https://doi.org/10.1519/JSC.0000000000003314
Harty, Patrick S, et al. "Position-Specific Body Composition Values in Female Collegiate Rugby Union Athletes." Journal of strength and conditioning research vol. (2019). doi: https://doi.org/10.1519/JSC.0000000000003314
Harty PS, Zabriskie HA, Stecker RA, Currier BS, Moon JM, Richmond SR, Jagim AR, Kerksick CM. Position-Specific Body Composition Values in Female Collegiate Rugby Union Athletes. J Strength Cond Res. 2019 Aug 08; doi: 10.1519/JSC.0000000000003314. Epub 2019 Aug 08. PMID: 31403573.
Copy Download .nbib Format: NLM
Does sitting versus standing radiographic assessment of odontoid fractures matter? A case report.

Journal of spine surgery (Hong Kong)

Aleem IS, Gussous Y, King M, Fogelson J, Nassr A, Currier BL.
PMID: 28744514
J Spine Surg. 2017 Jun;3(2):283-286. doi: 10.21037/jss.2017.05.12.

Fractures of the odontoid are the most common cervical spine injury in the geriatric population. The relationship between odontoid fracture displacement and postural change has not been previously described. We present the first described case of an elderly female...

Cite
Aleem IS, Gussous Y, King M, et al. Does sitting versus standing radiographic assessment of odontoid fractures matter? A case report. J Spine Surg. 2017;3(2):283-286doi: 10.21037/jss.2017.05.12.
Aleem, I. S., Gussous, Y., King, M., Fogelson, J., Nassr, A., & Currier, B. L. (2017). Does sitting versus standing radiographic assessment of odontoid fractures matter? A case report. Journal of spine surgery (Hong Kong), 3(2), 283-286. https://doi.org/10.21037/jss.2017.05.12
Aleem, Ilyas S, et al. "Does sitting versus standing radiographic assessment of odontoid fractures matter? A case report." Journal of spine surgery (Hong Kong) vol. 3,2 (2017): 283-286. doi: https://doi.org/10.21037/jss.2017.05.12
Aleem IS, Gussous Y, King M, Fogelson J, Nassr A, Currier BL. Does sitting versus standing radiographic assessment of odontoid fractures matter? A case report. J Spine Surg. 2017 Jun;3(2):283-286. doi: 10.21037/jss.2017.05.12. PMID: 28744514; PMCID: PMC5506295.
Copy Download .nbib Format: NLM
Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery.

Asian spine journal

Sebastian AS, Wanderman NR, Currier BL, Pichelmann MA, Treder VM, Fogelson JL, Clarke MJ, Nassr AN.
PMID: 30866616
Asian Spine J. 2019 Mar 15;13(4):544-555. doi: 10.31616/asj.2018.0277. Print 2019 Aug.

STUDY DESIGN: Prospective observational cohort study.PURPOSE: This study aims to evaluate the safety and efficacy of bone morphogenetic protein-2 (BMP-2) in transforaminal lumbar interbody fusion (TLIF) with regard to postoperative radiculitis.OVERVIEW OF LITERATURE: Bone morphogenetic protein (BMP) is being...

Cite
Sebastian AS, Wanderman NR, Currier BL, et al. Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery. Asian Spine J. 2019;13(4):544-555doi: 10.31616/asj.2018.0277.
Sebastian, A. S., Wanderman, N. R., Currier, B. L., Pichelmann, M. A., Treder, V. M., Fogelson, J. L., Clarke, M. J., & Nassr, A. N. (2019). Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery. Asian spine journal, 13(4), 544-555. https://doi.org/10.31616/asj.2018.0277
Sebastian, Arjun S, et al. "Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery." Asian spine journal vol. 13,4 (2019): 544-555. doi: https://doi.org/10.31616/asj.2018.0277
Sebastian AS, Wanderman NR, Currier BL, Pichelmann MA, Treder VM, Fogelson JL, Clarke MJ, Nassr AN. Prospective Evaluation of Radiculitis following Bone Morphogenetic Protein-2 Use for Transforaminal Interbody Arthrodesis in Spine Surgery. Asian Spine J. 2019 Mar 15;13(4):544-555. doi: 10.31616/asj.2018.0277. Print 2019 Aug. PMID: 30866616; PMCID: PMC6680045.
Copy Download .nbib Format: NLM
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

Cell reports

Joyce MG, Chen WH, Sankhala RS, Hajduczki A, Thomas PV, Choe M, Martinez EJ, Chang WC, Peterson CE, Morrison EB, Smith C, Chen RE, Ahmed A, Wieczorek L, Anderson A, Case JB, Li Y, Oertel T, Rosado L, Ganesh A, Whalen C, Carmen JM, Mendez-Rivera L, Karch CP, Gohain N, Villar Z, McCurdy D, Beck Z, Kim J, Shrivastava S, Jobe O, Dussupt V, Molnar S, Tran U, Kannadka CB, Soman S, Kuklis C, Zemil M, Khanh H, Wu W, Cole MA, Duso DK, Kummer LW, Lang TJ, Muncil SE, Currier JR, Krebs SJ, Polonis VR, Rajan S, McTamney PM, Esser MT, Reiley WW, Rolland M, de Val N, Diamond MS, Gromowski GD, Matyas GR, Rao M, Michael NL, Modjarrad K.
PMID: 34919799
Cell Rep. 2021 Dec 08;110143. doi: 10.1016/j.celrep.2021.110143. Epub 2021 Dec 08.

The need for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) next-generation vaccines has been highlighted by the rise of variants of concern (VoCs) and the long-term threat of emerging coronaviruses. Here, we design and characterize four categories of engineered...

Cite
Joyce MG, Chen WH, Sankhala RS, et al. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Cell Rep. 2021;110143doi: 10.1016/j.celrep.2021.110143.
Joyce, M. G., Chen, W. H., Sankhala, R. S., Hajduczki, A., Thomas, P. V., Choe, M., Martinez, E. J., Chang, W. C., Peterson, C. E., Morrison, E. B., Smith, C., Chen, R. E., Ahmed, A., Wieczorek, L., Anderson, A., Case, J. B., Li, Y., Oertel, T., Rosado, L., Ganesh, A., Whalen, C., Carmen, J. M., Mendez-Rivera, L., Karch, C. P., Gohain, N., Villar, Z., McCurdy, D., Beck, Z., Kim, J., Shrivastava, S., Jobe, O., Dussupt, V., Molnar, S., Tran, U., Kannadka, C. B., Soman, S., Kuklis, C., Zemil, M., Khanh, H., Wu, W., Cole, M. A., Duso, D. K., Kummer, L. W., Lang, T. J., Muncil, S. E., Currier, J. R., Krebs, S. J., Polonis, V. R., Rajan, S., McTamney, P. M., Esser, M. T., Reiley, W. W., Rolland, M., de Val, N., Diamond, M. S., Gromowski, G. D., Matyas, G. R., Rao, M., Michael, N. L., & Modjarrad, K. (2021). SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Cell reports, 110143. https://doi.org/10.1016/j.celrep.2021.110143
Joyce, M Gordon, et al. "SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity." Cell reports vol. (2021): 110143. doi: https://doi.org/10.1016/j.celrep.2021.110143
Joyce MG, Chen WH, Sankhala RS, Hajduczki A, Thomas PV, Choe M, Martinez EJ, Chang WC, Peterson CE, Morrison EB, Smith C, Chen RE, Ahmed A, Wieczorek L, Anderson A, Case JB, Li Y, Oertel T, Rosado L, Ganesh A, Whalen C, Carmen JM, Mendez-Rivera L, Karch CP, Gohain N, Villar Z, McCurdy D, Beck Z, Kim J, Shrivastava S, Jobe O, Dussupt V, Molnar S, Tran U, Kannadka CB, Soman S, Kuklis C, Zemil M, Khanh H, Wu W, Cole MA, Duso DK, Kummer LW, Lang TJ, Muncil SE, Currier JR, Krebs SJ, Polonis VR, Rajan S, McTamney PM, Esser MT, Reiley WW, Rolland M, de Val N, Diamond MS, Gromowski GD, Matyas GR, Rao M, Michael NL, Modjarrad K. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Cell Rep. 2021 Dec 08;110143. doi: 10.1016/j.celrep.2021.110143. Epub 2021 Dec 08. PMID: 34919799; PMCID: PMC8651551.
Copy Download .nbib Format: NLM
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.

medRxiv : the preprint server for health sciences

Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan D.
PMID: 34931202
medRxiv. 2021 Dec 14; doi: 10.1101/2021.12.13.21267611.

BACKGROUND: The efficacy of SARS-CoV-2 convalescent plasma (CCP) for preventing infection in exposed, uninfected individuals is unknown. We hypothesized that CCP might prevent infection when administered before symptoms or laboratory evidence of infection.METHODS: This double-blinded, phase 2 randomized, controlled...

Cite
Shoham S, Bloch EM, Casadevall A, et al. Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection. medRxiv. 2021;doi: 10.1101/2021.12.13.21267611.
Shoham, S., Bloch, E. M., Casadevall, A., Hanley, D., Lau, B., Gebo, K., Cachay, E., Kassaye, S. G., Paxton, J. H., Gerber, J., Levine, A. C., Currier, J., Patel, B., Allen, E. S., Anjan, S., Appel, L., Baksh, S., Blair, P. W., Bowen, A., Broderick, P., Caputo, C. A., Cluzet, V., Cordisco, M. E., Cruser, D., Ehrhardt, S., Forthal, D., Fukuta, Y., Gawad, A. L., Gniadek, T., Hammel, J., Huaman, M. A., Jabs, D. A., Jedlicka, A., Karlen, N., Klein, S., Laeyendecker, O., Lane, K., McBee, N., Meisenberg, B., Merlo, C., Mosnaim, G., Park, H. S., Pekosz, A., Petrini, J., Rausch, W., Shade, D. M., Shapiro, J. R., Singleton, J. R., Sutcliffe, C., Thomas, D. L., Yarava, A., Zand, M., Zenilman, J. M., Tobian, A. A. R., & Sullivan, D. (2021). Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.13.21267611
Shoham, Shmuel, et al. "Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.13.21267611
Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan D. Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection. medRxiv. 2021 Dec 14; doi: 10.1101/2021.12.13.21267611. PMID: 34931202; PMCID: PMC8687473.
Copy Download .nbib Format: NLM
Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia.

JACC. Case reports

Truong KP, Zhang JJ, Shahid M, Goud A, Rosove M, Currier J, Shamsa K, Parikh RV.
PMID: 34729516
JACC Case Rep. 2021 Oct 20;3(14):1625-1629. doi: 10.1016/j.jaccas.2021.06.022. eCollection 2021 Oct 20.

In the present case report, we describe the management of severe coronary artery disease in a patient with Glanzmann thrombasthenia. To the best of our knowledge, there are no established guidelines for revascularization in this setting, and we pose...

Cite
Truong KP, Zhang JJ, Shahid M, et al. Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia. JACC Case Rep. 2021;3(14):1625-1629doi: 10.1016/j.jaccas.2021.06.022.
Truong, K. P., Zhang, J. J., Shahid, M., Goud, A., Rosove, M., Currier, J., Shamsa, K., & Parikh, R. V. (2021). Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia. JACC. Case reports, 3(14), 1625-1629. https://doi.org/10.1016/j.jaccas.2021.06.022
Truong, Katie P, et al. "Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia." JACC. Case reports vol. 3,14 (2021): 1625-1629. doi: https://doi.org/10.1016/j.jaccas.2021.06.022
Truong KP, Zhang JJ, Shahid M, Goud A, Rosove M, Currier J, Shamsa K, Parikh RV. Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia. JACC Case Rep. 2021 Oct 20;3(14):1625-1629. doi: 10.1016/j.jaccas.2021.06.022. eCollection 2021 Oct 20. PMID: 34729516; PMCID: PMC8543141.
Copy Download .nbib Format: NLM
In Memoriam: Scott M. Hammer, MD.

Journal of the International AIDS Society

El-Sadr WM, Currier JS, Corey L.
PMID: 34877808
J Int AIDS Soc. 2021 Dec;24(12):e25856. doi: 10.1002/jia2.25856.

No abstract available.

Cite
El-Sadr WM, Currier JS, Corey L. In Memoriam: Scott M. Hammer, MD. J Int AIDS Soc. 2021;24(12):e25856doi: 10.1002/jia2.25856.
El-Sadr, W. M., Currier, J. S., & Corey, L. (2021). In Memoriam: Scott M. Hammer, MD. Journal of the International AIDS Society, 24(12), e25856. https://doi.org/10.1002/jia2.25856
El-Sadr, Wafaa M, et al. "In Memoriam: Scott M. Hammer, MD." Journal of the International AIDS Society vol. 24,12 (2021): e25856. doi: https://doi.org/10.1002/jia2.25856
El-Sadr WM, Currier JS, Corey L. In Memoriam: Scott M. Hammer, MD. J Int AIDS Soc. 2021 Dec;24(12):e25856. doi: 10.1002/jia2.25856. PMID: 34877808.
Copy Download .nbib Format: NLM
Showing 181 to 192 of 203 entries